Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.42 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL421101 | 0.86 | EHMT2 (0.61) | ALDH1A1EHMT2EHMT1APOBEC3GSMN1; SMN2 | |
| Bicarbonate SCHEMBL16975005 | 0.86 | ALDH1A1 (0.53) | ALDH1A1EHMT2EHMT1APOBEC3GSMN1; SMN2 | |
| Carbamic Acid SCHEMBL16975014 | 0.82 | ALDH1A1 (0.50) | ALDH1A1EHMT2EHMT1APOBEC3GSMN1; SMN2 | |
| Acrylic Acid SCHEMBL1500467 | 0.81 | ALDH1A1 (0.46) | ALDH1A1EHMT2EHMT1APOBEC3GSMN1; SMN2 | |
| Propionic Acid SCHEMBL6660723 | 0.81 | ALDH1A1 (0.54) | ALDH1A1EHMT2EHMT1APOBEC3GSMN1; SMN2 | |
| SCHEMBL14059364 | 0.81 | LMNA (0.53) | ALDH1A1SMN1; SMN2HPGDHSD17B10KMT2A | |
| SCHEMBL35924 | 0.80 | — | — | |
| SCHEMBL15255079 | 0.79 | ALDH1A1 (0.42) | ALDH1A1EHMT2EHMT1APOBEC3GSMN1; SMN2 | |
| Methacrylic Acid SCHEMBL28950373 | 0.78 | EHMT2 (0.46) | ALDH1A1EHMT2EHMT1APOBEC3GSMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL7972300 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025226869-A1 | GLUCOSE-RESPONSIVE GLUCAGON-MICELLE FOR THE PREVENTION OF HYPOGLYCEMIA AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-30 | — | — | WO | claimed |
| US-20250276000-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2025-09-04 | — | — | US | claimed |
| US-20180221402-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | ROIVANT SCIENCES LTD. (GB) | 2018-08-09 | — | — | US | claimed |
| US-20180140710-A1 | POLYMERS AND POLYMERIC ASSEMBLIES FOR PEPTIDE AND PROTEIN ENCAOSULATION AND RELEASE, AND METHODS THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-05-24 | — | — | US | claimed |
| EP-3292155-A1 | POLYMERS AND POLYMERIC ASSEMBLIES FOR PEPTIDE AND PROTEIN ENCAOSULATION AND RELEASE, AND METHODS THEREOF | University of Massachusetts (US) | 2018-03-14 | — | — | EP | claimed |
| CN-107530436-A | Methods, compositions and systems for delivering therapeutic and diagnostic agents into cells | 菲泽尔克斯公司 | 2018-01-02 | — | — | CN | claimed |
| EP-3247328-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PhaseRx, Inc. (US) | 2017-11-29 | — | — | EP | claimed |
| WO-2016179189-A1 | POLYMERS AND POLYMERIC ASSEMBLIES FOR PEPTIDE AND PROTEIN ENCAOSULATION AND RELEASE, AND METHODS THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 2016-11-10 | — | — | WO | claimed |
| WO-2016118697-A9 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-09-29 | — | — | WO | claimed |
| WO-2016118697-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | PHASERX, INC. (US) | 2016-07-28 | — | — | WO | claimed |
| US-9220791-B2 | Bispecific intracellular delivery vehicles | UNIVERSITY OF WASHINGTON (US) | 2015-12-29 | — | — | US | claimed |
| US-20140294752-A1 | METHOD FOR NUCLEIC ACID DELIVERY USING HYALURONIC ACID | Research & Business Foundation Sungkyunkwan University (KR) | 2014-10-02 | — | — | US | claimed |
| US-20140228516-A1 | BISPECIFIC INTRACELLULAR DELIVERY VEHICLES | PHASERX, INC. (US) | 2014-08-14 | — | — | US | claimed |
| EP-2620161-A1 | Diblock copolymers and polynucleotide complexes thereof for delivery into cells | University of Washington (US) | 2013-07-31 | — | — | EP | claimed |
| EP-3247328-B1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2026-01-07 | — | — | EP | disclosed |
| WO-2025226869-A1 | GLUCOSE-RESPONSIVE GLUCAGON-MICELLE FOR THE PREVENTION OF HYPOGLYCEMIA AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20250276000-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | GENEVANT SCIENCES GMBH (CH) | 2025-09-04 | — | — | US | disclosed |
| WO-2009140427-A2 | DIBLOCK COPOLYMERS AND POLYNUCLEOTIDE COMPLEXES THEREOF FOR DELIVERY INTO CELLS | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140429-A2 | MICELLIC ASSEMBLIES | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009140432-A2 | MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF WASHINGTON (US) | 2009-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250276000-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | CD63, LIPA, NPC1L1 | ALDH1A1 3899/4885EHMT2 4251/4885EHMT1 4421/4885 |
| US-20180140710-A1 | POLYMERS AND POLYMERIC ASSEMBLIES FOR PEPTIDE AND PROTEIN ENCAOSULATION AND RELEASE, AND METHODS THEREOF | ECPAS, IAPP, SPPL2B | ALDH1A1 4659/4885EHMT2 3525/4885EHMT1 3519/4885 |
| US-20140294752-A1 | METHOD FOR NUCLEIC ACID DELIVERY USING HYALURONIC ACID | CD44, DNASE1, HNRNPH3 | ALDH1A1 1523/4885EHMT2 2571/4885EHMT1 2304/4885 |
| US-20140228516-A1 | BISPECIFIC INTRACELLULAR DELIVERY VEHICLES | CD47, LNPK, ACTB | ALDH1A1 4522/4885EHMT2 4026/4885EHMT1 4334/4885 |
| US-20180221402-A1 | METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS | CD63, LIPA, NPC1L1 | ALDH1A1 3899/4885EHMT2 4251/4885EHMT1 4421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.